For citations:
Rukavitsyn O.A., Pop V.P., Drozd M.V., Ryabukhina Yu.E. A clinical case of the effective combined use of BCL-2 and PI3K inhibitors in the treatment of a patient with an unfavorable chronic lymphocytic leukemia with transformation into diffuse large B-cell lymphoma (Richter’s syndrome). Oncohematology. 2022;17(4):38-47. (In Russ.) https://doi.org/10.17650/1818-8346-2022-17-4-38-47
Email this article 